Literature DB >> 23240771

Population pharmacokinetics and pharmacogenetics of alcohol in Chinese and Indians in Singapore.

K Y Seng1, L M G Limenta, D Heng, E J D Lee.   

Abstract

WHAT IS KNOWN AND
OBJECTIVE: Interindividual variability in alcohol pharmacokinetics is influenced by a number of factors, including polymorphisms in genes mediating alcohol pharmacology, ethnicity, sex and body size. Several studies have evaluated the population pharmacokinetics of alcohol from breath alcohol measures. None of these studies, however, have evaluated ethnicity and alcohol-metabolizing enzyme genotypes as covariates in their population pharmacokinetic modelling. We aimed to develop a population pharmacokinetic model using clinical and genetic factors and to identify covariates that influenced interindividual variability in alcohol clearance and volume of distribution.
METHODS: Hundred and eighty healthy subjects (90 Chinese and 90 Indians; 45 males and 45 females from each ethnic group) ingested a vodka-orange juice mixture to simulate social drinking. Subjects were genotyped for the ADH1B (Arg48His), ALDH2 (Glu504Lys) and CYP2E1 (c.-1293G>C and c.-1053C>T) polymorphisms. A base pharmacokinetic model was developed using the nonmem software (NONMEM Project Group, University of California, San Francisco, San Francisco, CA, USA) to determine the alcohol clearance and volume of distribution. The model was extended to include covariates that influenced the between-subject variability. RESULTS AND DISCUSSION: Body weight and sex significantly influenced absorption rate and volume of distribution of alcohol. Body weight and ADH1B Arg48His polymorphism significantly influenced alcohol clearance. The Michaelis-Menten elimination rate (Vmax ) was decreased by 10% in homozygous ADH1B*1/*1 subjects. Ethnicity was not determined to be a significant covariate in the final population pharmacokinetic model. WHAT IS NEW AND
CONCLUSION: Gender and body weight were covariates that contributed most to explaining the observed interindividual alcohol pharmacokinetic variability. Of the four SNPs examined in this study, only ADH1B Arg48His polymorphism had a significant, though modest, effect on the pharmacokinetics of alcohol.
© 2012 Blackwell Publishing Ltd.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23240771     DOI: 10.1111/jcpt.12003

Source DB:  PubMed          Journal:  J Clin Pharm Ther        ISSN: 0269-4727            Impact factor:   2.512


  5 in total

1.  Analysis of Comprehensive Pharmacogenomic Profiling of VIP Variants Among the Genetically Isolated Chechen Subpopulation from Jordan.

Authors:  Laith N Al-Eitan; Doaa M Rababa'h; Nancy M Hakooz; Mansour A Alghamdi; Rana B Dajani
Journal:  Pharmgenomics Pers Med       Date:  2020-07-14

Review 2.  Ethanol pharmacokinetics in neonates and infants.

Authors:  Elizabeth Marek; Walter K Kraft
Journal:  Curr Ther Res Clin Exp       Date:  2014-10-22

3.  Genetic Polymorphisms of the Mitochondrial Aldehyde Dehydrogenase ALDH2 Gene in a Large Ethnic Hakka Population in Southern China.

Authors:  Zhixiong Zhong; Jingyuan Hou; Bin Li; Qifeng Zhang; Cunren Li; Zhidong Liu; Min Yang; Wei Zhong; Pingsen Zhao
Journal:  Med Sci Monit       Date:  2018-04-06

Review 4.  Lipids and Oxidative Stress Associated with Ethanol-Induced Neurological Damage.

Authors:  José A Hernández; Rosa C López-Sánchez; Adela Rendón-Ramírez
Journal:  Oxid Med Cell Longev       Date:  2016-01-05       Impact factor: 6.543

5.  A Bayesian Approach for Population Pharmacokinetic Modeling of Alcohol in Japanese Individuals.

Authors:  Asuka Nemoto; Matsuura Masaaki; Kazue Yamaoka
Journal:  Curr Ther Res Clin Exp       Date:  2017-04-10
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.